Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and...
-
Upload
griffin-hamilton -
Category
Documents
-
view
220 -
download
0
Transcript of Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and...
![Page 1: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/1.jpg)
Evidence-based Benefit Design
JOHN SANTA MD MPHGrant Administrator
Attorney Generals Consumer and Prescriber Grants Program
Center for Evidence-based PolicyOregon Health & Science University
![Page 2: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/2.jpg)
Systems are perfectly designed to get the results they achieve.
![Page 3: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/3.jpg)
“We can’t solve problems by using the same kind of thinking we used
when we created them.”
Albert Einstein
![Page 4: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/4.jpg)
The Ethics of Pharmaceutical Benefit Management
Burton S.L. et al, Health Affairs, 20, #5, Sept/Oct 2001
• Accept resource constraints• Help the sick• Protect the worst off• Respect autonomy• Sustain trust• Promote inclusive decision making
![Page 5: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/5.jpg)
Outline
• What is benefit design?• How did we get to here?• Any recent lessons learned?• Could evidence improve benefit
design?• How could evidence by integrated in
benefit design in ways that would make a difference?
• Focus on benefit design language
![Page 6: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/6.jpg)
What is Benefit Design
• Benefits• Delivery system• Membership
![Page 7: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/7.jpg)
Benefits
• Coverage• Rules• Exclusions
• Cost sharing• Administrative
incentives/disincentives
![Page 8: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/8.jpg)
Historical Development• Past efforts
• Employer based-----”earned entitlement”• 1960s Medicaid safety net• 1960s Medicare-----”earned entitlement”• Any “reasonable” benefit covered
• Successful vs. stressed purchasers
• Current efforts• Managed care in decline• “Consumer driven” increasing• Prescription drug coverage
![Page 9: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/9.jpg)
Financial Protection vs. Health• Financial Protection
• Indemnity—individual financial protection; little concern for health of the whole population.
• Better coverage for the more expensive services• Minimal limits on choice• Poorly informed value determinations
• Health• Prepaid plans—emphasis on prevention and anticipation
of illness• Better coverage for system approaches• Choice limited• Implicit value determinations—made by the system
![Page 10: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/10.jpg)
Consequences
• Increased costs• Lack of competition• Litigation• Mandates
![Page 11: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/11.jpg)
Consumer Driven
• Good preventive coverage (evidence-based usually) and catastrophic coverage, variable coverage for “middle benefits.”
• Variably effective information• Effective services as likely to be avoided
due to cost sharing as ineffective services• Obvious information gaps---error rates,
adverse events
![Page 12: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/12.jpg)
Prescription drug
• Tiering• Use of evidence• Price competition• Information competition
![Page 13: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/13.jpg)
State of research evidence
• Barriers• Strategies to overcome them
![Page 14: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/14.jpg)
Barriers
• Lack of sufficient evidence• Credibility and transparency• Synthesis and translation• Domination by researcher and
sellers
![Page 15: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/15.jpg)
Strategies to Overcome
• Systematic approaches---more evidence available than we realize. Lack of evidence can inform purchasing.
• Insist on credible, transparent processes• Collaborate---no need to duplicate.• Synthesis and translation need to be a
priority • Key questions---purchasers and
consumers need to get involved
![Page 16: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/16.jpg)
Integrating Evidence into Benefit Design
• Credibility, transparency, explicit• Systematic evidence synthesis• Make financial relationships explicit• Anticipate administrative costs• Design benefit language that
enables evidence to be used effectively
![Page 17: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/17.jpg)
Successful Evidence-based Design
• Benefit language• Incorporates evidence• Provides specificity• Understood by patients and practitioners
• Useful terminology• Currently used in claims• Will be in electronic records
• Tiers, levels, sliding scales that make sense• Financial• Admin
• Facilitates communication
![Page 18: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/18.jpg)
Benefit Design Languages
• Prescription drugs• Condition/Treatment pairs• Categories
![Page 19: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/19.jpg)
Prescription Drugs
• Tiering• Generics• Variable cost sharing—including no
cost sharing especially for “preventive” meds
• Emergence of evidence• Competition
![Page 20: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/20.jpg)
Condition/Treatment PairDiagnosis: ALLERGIC RHINITIS AND
CONJUNCTIVITIS, CHRONIC RHINITISTreatment: MEDICAL THERAPY ICD-9: 372.01-
372.05,372.14,372.54,372.56,472,477,995.3,V07.1
CPT: 30420,92002-92060,92070-92353,92358-92371,95004-95180,99024,99070,99078,99201-99362,99374-99375,99379-99440
Line: 597
![Page 21: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/21.jpg)
Condition/Treatment Pairs
• 700+ Pairs• Can be administered by insurers and
medical groups• Provides a stable actuarial base• Explicit use of evidence• ?Too much information
![Page 22: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/22.jpg)
Category Approach
• Groupings of Condition/Treatment pairs
• Acute, Chronic, Preventive, Other• Effectiveness• Importance
![Page 23: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/23.jpg)
Category 1: Acute fatal condition, treatment prevents death with full recovery AppendicitisCategory 2: Maternity care PregnancyCategory 3: Acute fatal condition, treatment prevents death without full recovery Severe head injuryCategory 4: Preventive care for children Preventive services birth to 10 years of ageCategory 5: Chronic fatal condition, treatment improves life span and quality of life Type I Diabetes
Category 6: Reproductive services (excluding maternity and infertility services) Birth ControlCategory 7: Comfort care Terminal illness regardless of cause
Category 8: Preventive dental care Preventive dental servicesCategory 9: Proven effective preventive care for adults Preventive svcs with proven effective services
above age 10 USPSTF A & B
Category 10: Acute non-fatal conditions, treatment causes return to previous health state GonorrheaCategory 11: Chronic non-fatal condition, one-time treatment improves quality of life Kidney stones
Category 12: Acute non-fatal condition, treatment does not result in a return to previous health state Internal derangement of knee
Category 13: Chronic non-fatal condition, repetitive treatment improves quality of life Breast cystsCategory 14: Self-limiting conditions where treatment expedites recovery Mononucleosis
Category 15: Infertility services Services improving fertilityCategory 16: Less effective preventive care for adults Ineffective preventive care USPSTF C, F & ICategory 17: Fatal or non-fatal condition, treatment causes minimal or no improvement in quality of life
Benign skin tumors
![Page 24: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/24.jpg)
Category Approach• ACUTE CONDITIONS/TREATMENTS• Category 1:Acute fatal condition, treatment prevents death with full recovery • Category 2:Acute fatal condition, treatment prevents death without full
recovery• Category 3:Acute non-fatal conditions, treatment causes return to previous
health state• Category 4:Acute non-fatal condition, treatment does not result in a return to
previous health state• PREVENTIVE CARE• Category 1:Maternity care• Category 2:Preventive care for children• Category 3:Preventive dental care• Category 4:Proven effective preventive care for adults• Category 5:Less effective preventive care for adults (including pregnant
women), children• CHRONIC CARE• Category 1:Chronic fatal condition, treatment improves life span and quality of
life• Category 2:Chronic non-fatal condition, one-time treatment improves quality of
life• Category 3:Chronic non-fatal condition, repetitive treatment improves quality of
life• OTHER CATEGORIES• Category :Reproductive services (excluding maternity and infertility services)• Category :Infertility services• Category :Fatal conditions, comfort care• Category :Fatal/non-fatal condition, treatment causes minimal/no improvement
in quality of life• Category :Self-limiting conditions where treatment expedites recovery
![Page 25: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/25.jpg)
Final Comments
• Benefit design a key tool• Emergence of electronic records,
systematic approach to evidence, creates tools
• Evidence not the only factor• “Not for the faint of heart.” • “Get serious or explore other options” • Redefine the playing field via benefit
design
![Page 26: Evidence-based Benefit Design JOHN SANTA MD MPH Grant Administrator Attorney Generals Consumer and Prescriber Grants Program Center for Evidence-based.](https://reader030.fdocuments.us/reader030/viewer/2022032706/56649de75503460f94ae0423/html5/thumbnails/26.jpg)
More Information
• Email comments/questions to [email protected].
• Call John Santa at 503-494-2691.